Role of Hepatic Transporters in the Disposition and Hepatotoxicity of a HER2 Tyrosine Kinase Inhibitor CP-724,714
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
CP-724,714, a potent and selective orally active HER2 tyrosine kinase inhibitor, was discontinued from clinical development due to unexpected hepatotoxicity in cancer patients. Based on the clinical manifestation of the toxicity, CP-724,714 likely exerted its hepatotoxicity via both hepatocellular injury and hepatobiliary cholestatic mechanisms. The direct cytotoxic effect, hepatobiliary disposition of CP-724,714, and its inhibition of active canalicular transport of bile constituents were evaluated in established human hepatocyte models and in vitro transporter systems. CP-724,714 exhibited direct cytotoxicity using human hepatocyte imaging assay technology with mitochondria identified as a candidate organelle for its off-target toxicity. Additionally, CP-724,714 was rapidly taken up into human hepatocytes, partially via an active transport process, with an uptake clearance approximately fourfold higher than efflux clearance. The major human hepatic uptake transporter, OATP1B1, and efflux transporters, multidrug resistance protein 1 (MDR1) and breast cancer resistance protein, were involved in hepatobiliary clearance of CP-724,714. Furthermore, CP-724,714 displayed a concentration-dependent inhibition of cholyl-lysyl fluorescein and taurocholate (TC) efflux into canaliculi in cryopreserved and fresh cultured human hepatocytes, respectively. Likewise, CP-724,714 inhibited TC transport in membrane vesicles expressing human bile salt export pump with an IC(50) of 16 microM. Finally, CP-724,714 inhibited the major efflux transporter in bile canaliculi, MDR1, with an IC(50) of approximately 28 microM. These results suggest that inhibition of hepatic efflux transporters contributed to hepatic accumulation of drug and bile constituents leading to hepatocellular injury and hepatobiliary cholestasis. This study provides likely explanations for clinically observed adverse liver effects of CP-724,714.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Considering that mechanisms leading to alterations in bile-acid homeostasis are believed in part to be responsible for recent prominent late-stage clinical attritions and black box warnings of novel therapeutics, including examples such as CP-724,714 (Feng et al. 2009), tolvaptan (Slizgi et al. 2016), AMG-009 (Morgan et al. 2013), and TAK-875 (Wolenski et al. 2017)”
From Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury (2017) · cites this paper as Feng et al. 2009
Citations
Cites
Büchler, M., König, J., Brom, M., Kartenbeck, J., Spring, H., Horie, T., & Keppler, D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15091 · Cited by 638
Hepatic Uptake of Bilirubin and Its Conjugates by the Human Organic Anion Transporter SLC21A6
Cui, Y., König, J., Leier, I., Buchholz, U., & Keppler, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004968200 · Cited by 515
Transporters as a determinant of drug clearance and tissue distribution
Shitara, Y., Horie, T., & Sugiyama, Y. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.12.003 · Cited by 496
Cellular Imaging Predictions of Clinical Drug-Induced Liver Injury
Xu, J. J., Henstock, P. V., Dunn, M. C., Smith, A. R., Chabot, J. R., & de Graaf, D. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn109 · Cited by 492
Self-citationFeng, B., Mills, J. B., Davidson, R. E., Mireles, R. J., Janiszewski, J. S., Troutman, M. D., & de Morais, S. M. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.017434 · Cited by 440
Self-citationJansen, P. L. M., Strautnieks, S. S., Jacquemin, E., Hadchouel, M., Sokal, E. M., Hooiveld, G. J. E. J., Koning, J. H., de Jager-Krikken, A., Kuipers, F., Stellaard, F., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70287-8 · Cited by 433
Byrne, J. A., Strautnieks, S. S., Mieli–Vergani, G., Higgins, C. F., Linton, K. J., & Thompson, R. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36591 · Cited by 337
Hepatobiliary transporters and drug‐induced cholestasis†
Pauli‐Magnus, C., & Meier, P. J. (2006) · Hepatology · doi:10.1002/hep.21359 · Cited by 285
Involvement of BCRP (ABCG2) in the Biliary Excretion of Pitavastatin
Hirano, M., Maeda, K., Matsushima, S., Nozaki, Y., Kusuhara, H., & Sugiyama, Y. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014019 · Cited by 256
Correlation of Biliary Excretion in Sandwich-Cultured Rat Hepatocytes and In Vivo in Rats
Liu, X., Chism, J. P., LeCluyse, E. L., Brouwer, K. R., & Brouwer, K. L. R. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15299-3 · Cited by 228
Biliary excretion in primary rat hepatocytes cultured in a collagen-sandwich configuration
Liu, X., LeCluyse, E. L., Brouwer, K. R., Gan, L.-S. L., Lemasters, J. J., Stieger, B., Meier, P. J., & Brouwer, K. L. R. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.277.1.g12 · Cited by 226 · cited 3×
“The equations used to calculate apparent uptake clearance (Uptakeapp), apparent intrinsic biliary clearance (CLbile,int,app) (Liu et al., 1999a), and biliary excretion index (BEI) (BEI was determined using B-CLEAR technology [Qualyst, Inc., Raleigh, NC]) (Liu et al., 1999b) over a 15-min interval are shown below.”
MethodUse of Cryopreserved Human Hepatocytes in Sandwich Culture to Measure Hepatobiliary Transport
Bi, Y.-A., Kazolias, D., & Duignan, D. B. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.009118 · Cited by 216 · cited 1×
“A detailed protocol for assessing hepatobiliary transport of drugs in sandwichcultured human hepatocytes was described previously (Bi et al., 2006; Kalgutkar et al., 2007).”
BackgroundSelf-citationThe Organic Anion Transporter (OATP) Family
Mikkaichi, T., Suzuki, T., Tanemoto, M., Ito, S., & Abe, T. (2004) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.19.171 · Cited by 191
Biliary secretion and excretion in health and disease: Current concepts
Hofmann, A. F. (2007) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31949-0 · Cited by 147
Keitel, V., Kartenbeck, J., Nies, A. T., Spring, H., Brom, M., & Keppler, D. (2000) · Hepatology · doi:10.1053/jhep.2000.19791 · Cited by 145
Campbell, S. D., de Morais, S. M., & Xu, J. J. (2004) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2004.08.008 · Cited by 144
Self-citationVallejo, M., Briz, Ó., Serrano, M. A., Monte, M. J., & Marı́n, J. J. G. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.09.017 · Cited by 134
BSEP: Function and Role in Progressive Familial Intrahepatic Cholestasis
Thompson, R., & Strautnieks, S. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-19038 · Cited by 133
Kostrubsky, V. E. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg217 · Cited by 132
Self-citationKostrubsky, S. E., Strom, S. C., Kalgutkar, A. S., Kulkarni, S., Atherton, J., Mireles, R., Feng, B., Kubik, R., Hanson, J., Urda, E., et al. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj095 · Cited by 121
Self-citationTransporters and Drug Discovery: Why, When, and How
Kim, R. B. (2006) · Molecular Pharmaceutics · doi:10.1021/mp050084o · Cited by 87
Yamano, K., Yamamoto, K., Katashima, M., Kotaki, H., Takedomi, S., Matsuo, H., Ohtani, H., Sawada, Y., & Iga, T. (2001) · PubMed · Cited by 80
Jani, J. P., Finn, R. S., Campbell, M., Coleman, K. G., Connell, R. D., Currier, N. V., Emerson, E. O., Floyd, E., Harriman, S. P., Kath, J. C., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3559 · Cited by 76
Hallifax, D., & Houston, J. B. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.010413 · Cited by 56
A 96-Well Efflux Assay To Identify ABCG2 Substrates Using a Stably Transfected MDCK II Cell Line
Xiao, Y., Davidson, R. E., Smith, A., Pereira, D. A., Zhao, S. X., Soglia, J. R., Gebhard, D. F., de Morais, S., & Duignan, D. B. (2006) · Molecular Pharmaceutics · doi:10.1021/mp050088t · Cited by 48
Self-citationKlaassen, C. D. (1973) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(73)90179-8 · Cited by 46
Munster, P. N., Britten, C. D., Mita, M., Gelmon, K., Minton, S. E., Moulder, S., Slamon, D. J., Guo, F., Letrent, S. P., Denis, L., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1539 · Cited by 38
Kostrubsky, S. E., Strom, S. C., Ellis, E. C. S., Nelson, S. D., & Mutlib, A. E. (2007) · Chemical Research in Toxicology · doi:10.1021/tx7001542 · Cited by 31
Morita, N., Kusuhara, H., Nozaki, Y., Endou, H., & Sugiyama, Y. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001552 · Cited by 26
Kalgutkar, A. S. S., Feng, B., Hang, N. T. T., Frederick, K. S., Campbell, S. D., Hatch, H. L., Bi, Y., Kazolias, D. C., Davidson, R. E., Mireles, R. J., et al. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.016162 · Cited by 24
Self-citationGuo, F., Letrent, S. P., Münster, P. N., Britten, C. D., Gelmon, K. A., Tolcher, A. W., & Sharma, A. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0579-4 · Cited by 17
A biliary milestone: Functional expression of the human bile salt export pump
Boyer, J. L. (2002) · Gastroenterology · doi:10.1053/gast.2002.36851 · Cited by 9
Cited by
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Self-citationSwift*, B., Pfeifer*, N. D., & Brouwer, K. L. R. (2010) · Drug Metabolism Reviews · doi:10.3109/03602530903491881 · Cited by 365
Morgan, R. E., Trauner, M., van Staden, C. J., Lee, P. H., Ramachandran, B., Eschenberg, M., Afshari, C. A., Qualls, C. W., Lightfoot-Dunn, R., & Hamadeh, H. K. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq269 · Cited by 325
Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury
Proctor, W. R., Foster, A. J., Vogt, J., Summers, C., Middleton, B., Pilling, M. A., Shienson, D., Kijanska, M., Ströbel, S., Kelm, J. M., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2002-1 · Cited by 328
“…responsible for recent prominent late-stage clinical attritions and black box warnings of novel therapeutics, including examples such as CP-724,714 (Feng et al. 2009), tolvaptan (Slizgi et al. 2016), AMG-009 (Morgan et al. 2013), and TAK-875 (Wolenski et al. 2017), there is an increasing need and…”
BackgroundObaidat, A., Roth, M., & Hagenbuch, B. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100556 · Cited by 295
Metadata
- Authors
- Feng, B., Xu, J. J., Bi, Y.-A., Mireles, R., Davidson, R., Duignan, D. B., Campbell, S., Kostrubsky, V. E., Dunn, M. C., Smith, A. R., & Wang, H. F.
- Affiliations
- Pfizer (United States) (US)
- Washington University in St. Louis (US)
- ORCID
- Feng, Bo
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-02-17
- Volume
- 108
- Issue
- 2
- Pages
- 492-500
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2144377055
- Cited by
- 80
- References
- 32
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 7 · 2018: 3 · 2017: 6 · 2016: 7 · 2015: 7 · 2014: 3 · 2013: 11 · 2012: 10
- FWCI
- 3.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Toxicological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- trastuzumab emtansine, HER2 tyrosine kinase inhibitor, hepatotoxicity, drug disposition, hepatic transporters, OATP1B1, MDR1, ABCG2, bile salt export pump, hepatocyte injury, drug-induced liver injury, mitochondrial toxicity, drug repurposing
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily G, Member 2, Multidrug Resistance-Associated Protein 2, Bile, Bile Acids and Salts, Calcium, Carrier Proteins, Cells, Cultured, Enzyme Inhibitors, Fluoresceins, Humans, Liver, Membrane Potentials, Neoplasm Proteins, Quinazolines, ATP Binding Cassette Transporter, Subfamily B, ATP-Binding Cassette Transporters, Receptor, ErbB-2, Erb-b2 Receptor Tyrosine Kinases, ATP Binding Cassette Transporter, Subfamily B, Member 1, Hepatocytes, Liver-Specific Organic Anion Transporter 1, Multidrug Resistance-Associated Proteins, ATP-Binding Cassette, Sub-Family C Proteins, Mitochondrial Membranes, Chemical and Drug Induced Liver Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.